153 related articles for article (PubMed ID: 18632189)
1. Memory loss caused by beta-amyloid protein is rescued by a beta(3)-adrenoceptor agonist.
Gibbs ME; Maksel D; Gibbs Z; Hou X; Summers RJ; Small DH
Neurobiol Aging; 2010 Apr; 31(4):614-24. PubMed ID: 18632189
[TBL] [Abstract][Full Text] [Related]
2. Reflections on glycogen and β-amyloid: why does glycogenolytic β2-adrenoceptor stimulation not rescue memory after β-amyloid?
Gibbs M
Metab Brain Dis; 2015 Feb; 30(1):345-52. PubMed ID: 24810634
[TBL] [Abstract][Full Text] [Related]
3. Rescue of Abeta(1-42)-induced memory impairment in day-old chick by facilitation of astrocytic oxidative metabolism: implications for Alzheimer's disease.
Gibbs ME; Gibbs Z; Hertz L
J Neurochem; 2009 May; 109 Suppl 1():230-6. PubMed ID: 19393032
[TBL] [Abstract][Full Text] [Related]
4. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.
Meunier J; Villard V; Givalois L; Maurice T
Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349
[TBL] [Abstract][Full Text] [Related]
5. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
[TBL] [Abstract][Full Text] [Related]
6. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
[TBL] [Abstract][Full Text] [Related]
7. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
[TBL] [Abstract][Full Text] [Related]
8. Ergothioneine protects against neuronal injury induced by β-amyloid in mice.
Yang NC; Lin HC; Wu JH; Ou HC; Chai YC; Tseng CY; Liao JW; Song TY
Food Chem Toxicol; 2012 Nov; 50(11):3902-11. PubMed ID: 22921351
[TBL] [Abstract][Full Text] [Related]
9. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
10. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
11. Beta2- and beta3-adrenoceptors activate glucose uptake in chick astrocytes by distinct mechanisms: a mechanism for memory enhancement?
Hutchinson DS; Summers RJ; Gibbs ME
J Neurochem; 2007 Nov; 103(3):997-1008. PubMed ID: 17680985
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress.
Li J; Wang C; Zhang JH; Cai JM; Cao YP; Sun XJ
Brain Res; 2010 Apr; 1328():152-61. PubMed ID: 20171955
[TBL] [Abstract][Full Text] [Related]
13. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
Dall'Igna OP; Fett P; Gomes MW; Souza DO; Cunha RA; Lara DR
Exp Neurol; 2007 Jan; 203(1):241-5. PubMed ID: 17007839
[TBL] [Abstract][Full Text] [Related]
14. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
15. Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice.
Villard V; Espallergues J; Keller E; Alkam T; Nitta A; Yamada K; Nabeshima T; Vamvakides A; Maurice T
Neuropsychopharmacology; 2009 May; 34(6):1552-66. PubMed ID: 19052542
[TBL] [Abstract][Full Text] [Related]
16. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
17. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Jing W; Guo F; Cheng L; Zhang JF; Qi JS
Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
[TBL] [Abstract][Full Text] [Related]
18. Exogenous galanin attenuates spatial memory impairment and decreases hippocampal β-amyloid levels in rat model of Alzheimer's disease.
Li L; Yu L; Kong Q
Int J Neurosci; 2013 Nov; 123(11):759-65. PubMed ID: 23687905
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
20. Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity.
Duclot F; Meffre J; Jacquet C; Gongora C; Maurice T
Neuroscience; 2010 May; 167(3):850-63. PubMed ID: 20219649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
